CLINICAL_TRIALS
trial_result
· 2015-10-29
Clinical Trial Update: Multicenter, Open-label, Safety and Tolerability Study [Phase 2]
Summary
Phase 2 multicenter open-label study evaluating safety and tolerability in schizophrenia; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2015-10-29